Table 3

Mean average values of symptomatic and therapeutic variables, and mean decrease in JSW during the first year of follow up, according to the sex of the patient. The symptomatic variables were collected at baseline and at months 1, 3, 6, 9, and 12. The structural variable was collected at entry and at year 1. Results are shown as mean (SD)

MeasuresWomenMenp Value (t test)p Value (Wilcoxon test)
Symptomatic data
    Pain (mm)39 (20)34 (19)0.0050.02
    Lequesne’s index6.7 (2.9)5.7 (2.7)0.0010.0003
    Patient’s assessment of disability (mm)37 (22)31 (19)0.0010.005
Change in joint space width (mm)0.31 (0.5)0.30 (0.5)0.840.7